GenomeNet

Database: UniProt
Entry: Q9UNH5
LinkDB: Q9UNH5
Original site: Q9UNH5 
ID   CC14A_HUMAN             Reviewed;         594 AA.
AC   Q9UNH5; B1AQ14; B1AQ15; O43171; O60727; O60728; Q52LH9; Q8IXX0;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2013, entry version 107.
DE   RecName: Full=Dual specificity protein phosphatase CDC14A;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=CDC14 cell division cycle 14 homolog A;
GN   Name=CDC14A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9367992; DOI=10.1074/jbc.272.47.29403;
RA   Li L., Ernsting B.R., Wishart M.J., Lohse D.L., Dixon J.E.;
RT   "A family of putative tumor suppressors is structurally and
RT   functionally conserved in humans and yeast.";
RL   J. Biol. Chem. 272:29403-29406(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10409437; DOI=10.1006/geno.1999.5863;
RA   Wong A.K.C., Chen Y., Lian L., Ha P.C., Petersen K., Laity K.,
RA   Carillo A., Emerson M., Heichman K., Gupte J., Tavtigian S.V.,
RA   Teng D.H.-F.;
RT   "Genomic structure, chromosomal location, and mutation analysis of the
RT   human CDC14A gene.";
RL   Genomics 59:248-251(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta;
RA   Hao L., Baskerville C., Charbonneau H.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-345 AND PHE-589.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DEPHOSPHORYLATION OF FZR1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   CYS-278.
RX   PubMed=11598127; DOI=10.1074/jbc.M108126200;
RA   Bembenek J., Yu H.;
RT   "Regulation of the anaphase-promoting complex by the dual specificity
RT   phosphatase human Cdc14a.";
RL   J. Biol. Chem. 276:48237-48242(2001).
RN   [9]
RP   SUBSTRATE SPECIFICITY, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF ASP-251; CYS-278 AND ARG-284.
RX   PubMed=12134069; DOI=10.1091/mbc.01-11-0535;
RA   Kaiser B.K., Zimmerman Z.A., Charbonneau H., Jackson P.K.;
RT   "Disruption of centrosome structure, chromosome segregation, and
RT   cytokinesis by misexpression of human Cdc14A phosphatase.";
RL   Mol. Biol. Cell 13:2289-2300(2002).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF MET-362 AND
RP   ILE-364.
RX   PubMed=11901424; DOI=10.1038/ncb777;
RA   Mailand N., Lukas C., Kaiser B.K., Jackson P.K., Bartek J., Lukas J.;
RT   "Deregulated human Cdc14A phosphatase disrupts centrosome separation
RT   and chromosome segregation.";
RL   Nat. Cell Biol. 4:317-322(2002).
RN   [11]
RP   INTERACTION WITH KIF20A, AND SUBCELLULAR LOCATION.
RX   PubMed=15263015; DOI=10.1083/jcb.200403084;
RA   Gruneberg U., Neef R., Honda R., Nigg E.A., Barr F.A.;
RT   "Relocation of Aurora B from centromeres to the central spindle at the
RT   metaphase to anaphase transition requires MKlp2.";
RL   J. Cell Biol. 166:167-172(2004).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] TYR-493.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Dual-specificity phosphatase. Required for centrosome
CC       separation and productive cytokinesis during cell division. May
CC       dephosphorylate the APC subunit FZR1/CDH1, thereby promoting APC-
CC       FZR1 dependent degradation of mitotic cyclins and subsequent exit
CC       from mitosis.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- CATALYTIC ACTIVITY: A phosphoprotein + H(2)O = a protein +
CC       phosphate.
CC   -!- SUBUNIT: Interacts with KIF20A, which is required to localize
CC       CDC14 to the midzone of the mitotic spindle.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton,
CC       centrosome. Cytoplasm, cytoskeleton, spindle. Note=Centrosomal
CC       during interphase, released into the cytoplasm at the onset of
CC       mitosis. Subsequently localizes to the midzone of the mitotic
CC       spindle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=CDC14A1;
CC         IsoId=Q9UNH5-1; Sequence=Displayed;
CC       Name=2; Synonyms=CDC14A2;
CC         IsoId=Q9UNH5-2; Sequence=VSP_012037;
CC       Name=3; Synonyms=CDC14A3;
CC         IsoId=Q9UNH5-3; Sequence=VSP_012035, VSP_012036;
CC       Name=4; Synonyms=CDC14A4;
CC         IsoId=Q9UNH5-4; Sequence=VSP_012322, VSP_012323;
CC         Note=No experimental confirmation available;
CC   -!- DOMAIN: Composed of two structurally equivalent A and B domains
CC       that adopt a dual specificity protein phosphatase (DSP) fold (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class CDC14 subfamily.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB88277.1; Type=Frameshift; Positions=6;
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc14a/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000367; AAB88277.1; ALT_FRAME; mRNA.
DR   EMBL; AF122013; AAD49217.1; -; mRNA.
DR   EMBL; AF064102; AAC16659.1; -; mRNA.
DR   EMBL; AF064103; AAC16660.1; -; mRNA.
DR   EMBL; AY623111; AAT38107.1; -; Genomic_DNA.
DR   EMBL; AL589990; CAH70068.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70068.1; JOINED; Genomic_DNA.
DR   EMBL; AL589990; CAH70069.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70069.1; JOINED; Genomic_DNA.
DR   EMBL; AL589990; CAH70070.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70070.1; JOINED; Genomic_DNA.
DR   EMBL; CH471097; EAW72956.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72958.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72959.1; -; Genomic_DNA.
DR   EMBL; BC038979; AAH38979.1; -; mRNA.
DR   EMBL; BC093916; AAH93916.1; -; mRNA.
DR   EMBL; BC093918; AAH93918.1; -; mRNA.
DR   IPI; IPI00021145; -.
DR   IPI; IPI00031770; -.
DR   IPI; IPI00217676; -.
DR   IPI; IPI00219831; -.
DR   RefSeq; NP_003663.2; NM_003672.3.
DR   RefSeq; NP_201569.1; NM_033312.2.
DR   RefSeq; NP_201570.1; NM_033313.2.
DR   UniGene; Hs.127411; -.
DR   ProteinModelPortal; Q9UNH5; -.
DR   MINT; MINT-8330048; -.
DR   STRING; 9606.ENSP00000354916; -.
DR   PhosphoSite; Q9UNH5; -.
DR   DMDM; 55976620; -.
DR   PaxDb; Q9UNH5; -.
DR   PRIDE; Q9UNH5; -.
DR   Ensembl; ENST00000336454; ENSP00000336739; ENSG00000079335.
DR   Ensembl; ENST00000361544; ENSP00000354916; ENSG00000079335.
DR   Ensembl; ENST00000370124; ENSP00000359142; ENSG00000079335.
DR   Ensembl; ENST00000370125; ENSP00000359143; ENSG00000079335.
DR   GeneID; 8556; -.
DR   KEGG; hsa:8556; -.
DR   UCSC; uc001dte.4; human.
DR   UCSC; uc001dtf.2; human.
DR   UCSC; uc001dtg.4; human.
DR   UCSC; uc009wec.1; human.
DR   CTD; 8556; -.
DR   GeneCards; GC01P100817; -.
DR   HGNC; HGNC:1718; CDC14A.
DR   HPA; HPA023783; -.
DR   MIM; 603504; gene.
DR   neXtProt; NX_Q9UNH5; -.
DR   PharmGKB; PA26254; -.
DR   eggNOG; COG2453; -.
DR   HOVERGEN; HBG050818; -.
DR   KO; K06639; -.
DR   OMA; ACEFMKD; -.
DR   Reactome; REACT_115566; Cell Cycle.
DR   BindingDB; Q9UNH5; -.
DR   ChEMBL; CHEMBL1772926; -.
DR   GenomeRNAi; 8556; -.
DR   NextBio; 32065; -.
DR   ArrayExpress; Q9UNH5; -.
DR   Bgee; Q9UNH5; -.
DR   CleanEx; HS_CDC14A; -.
DR   Genevestigator; Q9UNH5; -.
DR   GermOnline; ENSG00000079335; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:EC.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IEA:GOC.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR020422; Dual-sp_phosphatase_subgr_cat.
DR   InterPro; IPR026068; Dual_Pase_CDC14.
DR   InterPro; IPR000387; Tyr/Dual-sp_Pase.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   PANTHER; PTHR23339:SF27; PTHR23339:SF27; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Hydrolase; Nucleus; Polymorphism;
KW   Protein phosphatase; Reference proteome.
FT   CHAIN         1    594       Dual specificity protein phosphatase
FT                                CDC14A.
FT                                /FTId=PRO_0000094876.
FT   REGION        7    162       A.
FT   REGION      163    176       Linker.
FT   REGION      177    343       B.
FT   ACT_SITE    278    278       Phosphocysteine intermediate (By
FT                                similarity).
FT   VAR_SEQ     174    191       RVENGDFNWIVPGKFLAF -> VILFTPLKPTFLISKSIM
FT                                (in isoform 4).
FT                                /FTId=VSP_012322.
FT   VAR_SEQ     192    594       Missing (in isoform 4).
FT                                /FTId=VSP_012323.
FT   VAR_SEQ     380    383       DNLE -> VSFP (in isoform 3).
FT                                /FTId=VSP_012035.
FT   VAR_SEQ     384    594       Missing (in isoform 3).
FT                                /FTId=VSP_012036.
FT   VAR_SEQ     586    594       SLQSEYVHY -> VSAQTPPPGPQNPECNFCALPSQPRLPP
FT                                KKFNSAKEAF (in isoform 2).
FT                                /FTId=VSP_012037.
FT   VARIANT     345    345       R -> Q (in dbSNP:rs28364897).
FT                                /FTId=VAR_019957.
FT   VARIANT     493    493       D -> Y (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035655.
FT   VARIANT     589    589       S -> F (in dbSNP:rs28364923).
FT                                /FTId=VAR_019958.
FT   MUTAGEN     251    251       D->A: Loss of phosphatase activity.
FT   MUTAGEN     278    278       C->S: Loss of phosphatase activity.
FT   MUTAGEN     284    284       R->A: Loss of phosphatase activity.
FT   MUTAGEN     362    362       M->A: Inappropriate nucleolar
FT                                localization; when associated with A-364.
FT   MUTAGEN     364    364       I->A: Inappropriate nucleolar
FT                                localization; when associated with A-362.
FT   CONFLICT    164    164       F -> I (in Ref. 1; AAB88277).
FT   CONFLICT    182    182       W -> C (in Ref. 1; AAB88277).
SQ   SEQUENCE   594 AA;  66574 MW;  D5552E2BAEEA84DF CRC64;
     MAAESGELIG ACEFMKDRLY FATLRNRPKS TVNTHYFSID EELVYENFYA DFGPLNLAMV
     YRYCCKLNKK LKSYSLSRKK IVHYTCFDQR KRANAAFLIG AYAVIYLKKT PEEAYRALLS
     GSNPPYLPFR DASFGNCTYN LTILDCLQGI RKGLQHGFFD FETFDVDEYE HYERVENGDF
     NWIVPGKFLA FSGPHPKSKI ENGYPLHAPE AYFPYFKKHN VTAVVRLNKK IYEAKRFTDA
     GFEHYDLFFI DGSTPSDNIV RRFLNICENT EGAIAVHCKA GLGRTGTLIA CYVMKHYRFT
     HAEIIAWIRI CRPGSIIGPQ QHFLEEKQAS LWVQGDIFRS KLKNRPSSEG SINKILSGLD
     DMSIGGNLSK TQNMERFGED NLEDDDVEMK NGITQGDKLR ALKSQRQPRT SPSCAFRSDD
     TKGHPRAVSQ PFRLSSSLQG SAVTLKTSKM ALSPSATAKR INRTSLSSGA TVRSFSINSR
     LASSLGNLNA ATDDPENKKT SSSSKAGFTA SPFTNLLNGS SQPTTRNYPE LNNNQYNRSS
     NSNGGNLNSP PGPHSAKTEE HTTILRPSYT GLSSSSARFL SRSIPSLQSE YVHY
//
DBGET integrated database retrieval system